SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1u0o'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C4D_D_DVAD8_0
(GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 TRP B 265
VAL B 240
TRP B 223
 None
 1.15A 1c4dC-1u0oB:
undetectable
1c4dD-1u0oB:
undetectable		 1c4dC-1u0oB:
9.17
1c4dD-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C4D_D_DVAD8_0
(GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 TRP B 265
VAL B 320
TRP B 223
 None
 1.30A 1c4dC-1u0oB:
undetectable
1c4dD-1u0oB:
undetectable		 1c4dC-1u0oB:
9.17
1c4dD-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LZX_B_H4BB1760_1
(NITRIC-OXIDE
SYNTHASE)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.37A 1lzxA-1u0oC:
undetectable
1lzxB-1u0oC:
undetectable		 1lzxA-1u0oC:
21.57
1lzxB-1u0oC:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MMV_B_H4BB2760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.31A 1mmvA-1u0oC:
undetectable
1mmvB-1u0oC:
undetectable		 1mmvA-1u0oC:
21.57
1mmvB-1u0oC:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RS6_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 8 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.30A 1rs6A-1u0oC:
undetectable
1rs6B-1u0oC:
undetectable		 1rs6A-1u0oC:
21.14
1rs6B-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JN3_A_JN3A130_2
(FATTY ACID-BINDING
PROTEIN, LIVER)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
LEU C 621
GLU C 689
ARG C 686
 None
 0.84A 2jn3A-1u0oC:
undetectable		 2jn3A-1u0oC:
20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XDC_A_DVAA8_0
(GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 VAL B 320
TRP B 223
TRP B 265
 None
 1.26A 2xdcA-1u0oB:
undetectable
2xdcB-1u0oB:
undetectable		 2xdcA-1u0oB:
9.17
2xdcB-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XDC_B_DVAB8_0
(GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 TRP B 265
VAL B 320
TRP B 223
 None
 1.28A 2xdcA-1u0oB:
undetectable
2xdcB-1u0oB:
undetectable		 2xdcA-1u0oB:
9.17
2xdcB-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XDC_C_DVAC8_0
(GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 VAL B 320
TRP B 223
TRP B 265
 None
 1.32A 2xdcC-1u0oB:
undetectable
2xdcD-1u0oB:
undetectable		 2xdcC-1u0oB:
9.17
2xdcD-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XDC_D_DVAD8_0
(GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 TRP B 265
VAL B 320
TRP B 223
 None
 1.11A 2xdcC-1u0oB:
undetectable
2xdcD-1u0oB:
undetectable		 2xdcC-1u0oB:
9.17
2xdcD-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XDC_F_DVAF8_0
(GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 TRP B 265
VAL B 320
TRP B 223
 None
 1.15A 2xdcE-1u0oB:
undetectable
2xdcF-1u0oB:
undetectable		 2xdcE-1u0oB:
9.17
2xdcF-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y5M_A_DVAA8_0
(VAL-GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 VAL B 320
TRP B 223
TRP B 265
 None
 1.25A 2y5mA-1u0oB:
undetectable
2y5mB-1u0oB:
undetectable		 2y5mA-1u0oB:
9.17
2y5mB-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y5M_F_DVAF8_0
(VAL-GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 TRP B 265
VAL B 320
TRP B 223
 None
 1.12A 2y5mE-1u0oB:
undetectable
2y5mF-1u0oB:
undetectable		 2y5mE-1u0oB:
9.17
2y5mF-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y6N_A_DVAA8_0
(VAL-GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 VAL B 320
TRP B 223
TRP B 265
 None
 1.25A 2y6nA-1u0oB:
undetectable
2y6nB-1u0oB:
undetectable		 2y6nA-1u0oB:
9.17
2y6nB-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y6N_B_DVAB8_0
(VAL-GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 TRP B 265
VAL B 320
TRP B 223
 None
 1.26A 2y6nA-1u0oB:
undetectable
2y6nB-1u0oB:
undetectable		 2y6nA-1u0oB:
9.17
2y6nB-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y6N_D_DVAD8_0
(VAL-GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 TRP B 265
VAL B 320
TRP B 223
 None
 1.10A 2y6nC-1u0oB:
undetectable
2y6nD-1u0oB:
undetectable		 2y6nC-1u0oB:
9.17
2y6nD-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y6N_F_DVAF8_0
(VAL-GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 TRP B 265
VAL B 320
TRP B 223
 None
 1.10A 2y6nE-1u0oB:
undetectable
2y6nF-1u0oB:
undetectable		 2y6nE-1u0oB:
9.17
2y6nF-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AY0_A_ADNA401_1
(UNCHARACTERIZED
PROTEIN MJ0883)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		5 / 10 TYR C 693
ALA C 698
VAL C 553
LEU C 619
PHE C 517
 None
 1.40A 3ay0A-1u0oC:
undetectable		 3ay0A-1u0oC:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FRB_X_TOPX300_1
(DIHYDROFOLATE
REDUCTASE)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		5 / 11 LEU C 634
VAL C 648
SER C 658
ILE C 662
TYR C 558
 None
 1.11A 3frbX-1u0oC:
undetectable		 3frbX-1u0oC:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R55_A_PZAA598_0
(LACTOPEROXIDASE)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 GLU B 219
PHE B 319
GLN B 233
 None
 0.94A 3r55A-1u0oB:
undetectable		 3r55A-1u0oB:
10.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T7S_C_SAMC300_0
(PUTATIVE
METHYLTRANSFERASE)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		5 / 12 GLN C 590
GLY C 521
GLY C 588
SER C 562
ALA C 592
 None
 1.37A 3t7sC-1u0oC:
undetectable		 3t7sC-1u0oC:
21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.37A 3ufqA-1u0oC:
undetectable
3ufqB-1u0oC:
undetectable		 3ufqA-1u0oC:
21.14
3ufqB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZQ8_A_DVAA8_0
(VAL-GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 VAL B 320
TRP B 223
TRP B 265
 None
 1.26A 3zq8A-1u0oB:
undetectable
3zq8B-1u0oB:
undetectable		 3zq8A-1u0oB:
9.17
3zq8B-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZQ8_D_DVAD8_0
(VAL-GRAMICIDIN A)		 1u0o BOTROCETIN
(Bothrops
jararaca) 		3 / 3 TRP B 265
VAL B 240
TRP B 223
 None
 0.94A 3zq8C-1u0oB:
undetectable
3zq8D-1u0oB:
undetectable		 3zq8C-1u0oB:
9.17
3zq8D-1u0oB:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTV_B_H4BB1720_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.42A 4ctvA-1u0oC:
undetectable
4ctvB-1u0oC:
undetectable		 4ctvA-1u0oC:
21.14
4ctvB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5D_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.37A 4k5dA-1u0oC:
undetectable
4k5dB-1u0oC:
undetectable		 4k5dA-1u0oC:
21.14
4k5dB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M11_B_MXMB606_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		5 / 12 ILE C 653
LEU C 619
ALA C 674
LEU C 676
LEU C 677
 None
 1.03A 4m11B-1u0oC:
undetectable		 4m11B-1u0oC:
16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UGZ_B_H4BB760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.29A 4ugzA-1u0oC:
undetectable
4ugzB-1u0oC:
undetectable		 4ugzA-1u0oC:
21.14
4ugzB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH0_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.27A 4uh0A-1u0oC:
undetectable
4uh0B-1u0oC:
undetectable		 4uh0A-1u0oC:
21.14
4uh0B-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.32A 4uh3A-1u0oC:
undetectable
4uh3B-1u0oC:
undetectable		 4uh3A-1u0oC:
21.14
4uh3B-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPN_B_H4BB760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.39A 4upnA-1u0oC:
undetectable
4upnB-1u0oC:
undetectable		 4upnA-1u0oC:
21.14
4upnB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADA_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.31A 5adaA-1u0oC:
undetectable
5adaB-1u0oC:
undetectable		 5adaA-1u0oC:
21.14
5adaB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGK_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.41A 5agkA-1u0oC:
undetectable
5agkB-1u0oC:
undetectable		 5agkA-1u0oC:
21.14
5agkB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.41A 5agpA-1u0oC:
undetectable
5agpB-1u0oC:
undetectable		 5agpA-1u0oC:
21.14
5agpB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AXD_A_RBVA502_2
(ADENOSYLHOMOCYSTEINA
SE)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		3 / 3 THR C 581
HIS C 616
LEU C 568
 None
 0.79A 5axdA-1u0oC:
4.2		 5axdA-1u0oC:
18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AXD_C_RBVC502_2
(ADENOSYLHOMOCYSTEINA
SE)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		3 / 3 THR C 581
HIS C 616
LEU C 568
 None
 0.79A 5axdC-1u0oC:
undetectable		 5axdC-1u0oC:
18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0N_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 MET C 541
VAL C 691
PHE C 536
GLU C 542
 None
 1.38A 5g0nA-1u0oC:
undetectable
5g0nB-1u0oC:
undetectable		 5g0nA-1u0oC:
21.14
5g0nB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JQB_B_IBPB706_1
(ENVELOPE
GLYCOPROTEIN
1,ENVELOPE
GLYCOPROTEIN
1,ENVELOPE
GLYCOPROTEIN 1
ENVELOPE
GLYCOPROTEIN 2)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		5 / 8 ARG C 686
LEU C 683
LEU C 677
LEU C 619
LEU C 621
 None
 1.35A 5jqbA-1u0oC:
0.9
5jqbB-1u0oC:
undetectable		 5jqbA-1u0oC:
20.44
5jqbB-1u0oC:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSD_B_1GNB603_1
(PHIAB6 TAILSPIKE)		 1u0o BOTROCETIN
VON WILLEBRAND
FACTOR
(Bothrops
jararaca;
Mus
musculus) 		3 / 3 VAL C 591
GLU B 232
GLU B 228
 None
 0.93A 5jsdB-1u0oC:
undetectable
5jsdC-1u0oC:
undetectable		 5jsdB-1u0oC:
14.94
5jsdC-1u0oC:
14.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNR_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.35A 5unrA-1u0oC:
undetectable
5unrB-1u0oC:
undetectable		 5unrA-1u0oC:
21.14
5unrB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNT_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 MET C 541
VAL C 691
PHE C 536
GLU C 542
 None
 1.39A 5untA-1u0oC:
undetectable
5untB-1u0oC:
undetectable		 5untA-1u0oC:
21.14
5untB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNT_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.28A 5untA-1u0oC:
undetectable
5untB-1u0oC:
undetectable		 5untA-1u0oC:
21.14
5untB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNU_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.23A 5unuA-1u0oC:
undetectable
5unuB-1u0oC:
undetectable		 5unuA-1u0oC:
21.14
5unuB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNW_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.31A 5unwA-1u0oC:
undetectable
5unwB-1u0oC:
undetectable		 5unwA-1u0oC:
21.14
5unwB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNZ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.35A 5unzA-1u0oC:
undetectable
5unzB-1u0oC:
undetectable		 5unzA-1u0oC:
21.14
5unzB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUI_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 MET C 541
VAL C 691
PHE C 536
GLU C 542
 None
 1.33A 5vuiA-1u0oC:
undetectable
5vuiB-1u0oC:
undetectable		 5vuiA-1u0oC:
21.14
5vuiB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUI_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.24A 5vuiA-1u0oC:
undetectable
5vuiB-1u0oC:
undetectable		 5vuiA-1u0oC:
21.14
5vuiB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUK_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.37A 5vukA-1u0oC:
undetectable
5vukB-1u0oC:
undetectable		 5vukA-1u0oC:
21.14
5vukB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUM_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.37A 5vumA-1u0oC:
undetectable
5vumB-1u0oC:
undetectable		 5vumA-1u0oC:
21.14
5vumB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUR_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.37A 5vurA-1u0oC:
undetectable
5vurB-1u0oC:
undetectable		 5vurA-1u0oC:
21.14
5vurB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUS_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.38A 5vusA-1u0oC:
undetectable
5vusB-1u0oC:
undetectable		 5vusA-1u0oC:
21.14
5vusB-1u0oC:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUT_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 MET C 541
VAL C 691
PHE C 536
GLU C 542
 None
 1.29A 6autA-1u0oC:
undetectable
6autB-1u0oC:
undetectable		 6autA-1u0oC:
16.67
6autB-1u0oC:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUX_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 PHE C 536
GLU C 542
MET C 541
VAL C 691
 None
 1.40A 6auxA-1u0oC:
undetectable
6auxB-1u0oC:
undetectable		 6auxA-1u0oC:
16.67
6auxB-1u0oC:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 MET C 541
VAL C 691
PHE C 536
GLU C 542
 None
 1.31A 6av1A-1u0oC:
0.5
6av1B-1u0oC:
undetectable		 6av1A-1u0oC:
16.18
6av1B-1u0oC:
16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CIC_A_H4BA802_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 MET C 541
VAL C 691
PHE C 536
GLU C 542
 None
 1.33A 6cicA-1u0oC:
undetectable
6cicB-1u0oC:
undetectable		 6cicA-1u0oC:
16.18
6cicB-1u0oC:
16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CID_A_H4BA802_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		4 / 7 MET C 541
VAL C 691
PHE C 536
GLU C 542
 None
 1.30A 6cidA-1u0oC:
undetectable
6cidB-1u0oC:
undetectable		 6cidA-1u0oC:
16.18
6cidB-1u0oC:
16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EMU_C_SAMC301_0
(TRNA
(GUANINE(9)-/ADENINE
(9)-N1)-METHYLTRANSF
ERASE)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		5 / 12 LEU C 619
THR C 594
ILE C 617
VAL C 646
ILE C 649
 None
 0.91A 6emuC-1u0oC:
2.3		 6emuC-1u0oC:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 1u0o VON WILLEBRAND
FACTOR
(Mus
musculus) 		3 / 3 ARG C 686
PHE C 507
PHE C 675
 None
 1.04A 6nknC-1u0oC:
0.0
6nknJ-1u0oC:
undetectable		 6nknC-1u0oC:
19.19
6nknJ-1u0oC:
14.77